Marker Therapeutics (MRKR) EBITDA Margin (2018 - 2022)
Marker Therapeutics' EBITDA Margin was -139.65% in Q1 2023, up 816.30 percentage points from -955.95% a year earlier and up 153.52 percentage points from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) EBITDA Margin (2018 - 2022) Analysis & Trends
On a trailing twelve-month basis, Marker Therapeutics' EBITDA Margin was -305.24% through Mar 31, 2023, up 2308.20 percentage points year-over-year; for FY2022, it was -483.90%, up 2522.36 percentage points from FY2021.
- EBITDA Margin has now increased for four consecutive years, with a four-year change of +71446.18 percentage points (FY2018 to FY2022).
- In earlier years, EBITDA Margin was -3006.26% in FY2021 (+2673.78 pp), -5680.03% in FY2020 (+4837.94 pp), -10517.97% in FY2019 (+61412.10 pp) and -71930.07% in FY2018.
- The Q1 2023 figure marks the highest quarterly EBITDA Margin in data going back to Q2 2018.
- Per Business Quant data, MRKR's EBITDA Margin in the three quarters before Q1 2023 was -293.17% (Q4 2022), -500.87% (Q3 2022) and -593.13% (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 39.16% |
| 10 | Marker Therapeutics | 17.87 Mn | -42.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -293.17% |
| Sep 30, 2022 | -500.87% |
| Jun 30, 2022 | -593.13% |
| Mar 31, 2022 | -955.95% |
| Dec 31, 2020 | -24,975.34% |
| Jun 30, 2020 | -1,342.84% |
| Dec 31, 2019 | -2,499.05% |
| Jun 30, 2018 | -2,268.90% |
API Access
Marker Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();